http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015037275-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5053f82a7cd17c60822674b657cfb89e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48969
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48176
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
filingDate 2014-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e13f5514fa42ebfb804c3bcc5c58a4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3739e61d9f77f1c7a5c1e4873ef0440
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f44b88f795e587053ca53040cb30f49f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a712982297f3a598cbe859a92ce96a0
publicationDate 2015-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2015037275-A1
titleOfInvention Rifaximin complexes
abstract There is provided a complex comprising rifaximin and a complexing agent, wherein the complexing agent is a polyvinyl pyrrolidone (PVP) or a cyclodextrin. There is also provided a process for preparing the complex, a pharmaceutical composition including the complex and therapeutic uses of the complex.
priorityDate 2008-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003078215-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8916193-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423592648
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID29565
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID29565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425229519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID311232967
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID224735021
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226495047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226495048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57507834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58352721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426098818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57507833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131732184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411809709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID348042441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230467520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID323270323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID347930476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID117849361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582371

Total number of triples: 71.